Physician profile
Alla Sragets
NPI 1013956978
$394.30
in general payments reported to CMS, 2019-2025
10 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.96 · 2021: $32.35 · 2022: $42.08 · 2023: $64.90 · 2024: $45.09 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $145.81 | 2019-2023 | Gardasil 9, Vaxneuvance, Vaxelis |
| Organon LLC | $52.50 | 2021-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $45.09 | 2024 | Thinprep 2000 Processor, Aptima |
| Lilly USA, LLC | $26.87 | 2025 | Mounjaro, Zepbound |
| Sanofi Pasteur INC. | $26.62 | 2025 | |
| Evofem Biosciences, INC. | $25.00 | 2022 | |
| Astellas Pharma US INC | $20.31 | 2025 | Veozah |
| Shield Therapeutics INC | $19.08 | 2025 | |
| Scilex Pharmaceuticals INC. | $17.08 | 2022 | |
| Cranial Technologies, INC | $15.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alla Sragets listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.